[
    [
        {
            "time": "",
            "original_text": "最新数据：全国688品规过评，苯磺酸氨氯地平片、盐酸二甲双胍片过评企业超20！",
            "features": {
                "keywords": [
                    "全国",
                    "688品规",
                    "过评",
                    "苯磺酸氨氯地平片",
                    "盐酸二甲双胍片"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "最新数据：全国688品规过评，苯磺酸氨氯地平片、盐酸二甲双胍片过评企业超20！",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【最新过评】中国最贵药品首仿获批，恒瑞第12个过评品种诞生！",
            "features": {
                "keywords": [
                    "中国",
                    "最贵药品",
                    "首仿",
                    "恒瑞",
                    "过评品种"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【最新过评】中国最贵药品首仿获批，恒瑞第12个过评品种诞生！",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "大摩：最新中港市场焦点股及估值预测",
            "features": {
                "keywords": [
                    "大摩",
                    "中港市场",
                    "焦点股",
                    "估值预测"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "大摩：最新中港市场焦点股及估值预测",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]